Medical Statistician Doug Altman Dies

The cofounder of the EQUATOR Network devoted his career to boosting transparency and improving the quality of clinical research.

Written byKerry Grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

NDORMS, UNIVERSITY OF OXFORDDoug Altman, a professor of statistics at the University of Oxford, died June 3. He was 69 years old. Altman was revered for his statistical methodologies in medical research and his work to develop best practices for clinical studies as the cofounder and former director of the Centre for Statistics in Medicine at Oxford and the cofounder of the EQUATOR Network.

“Doug Altman was an outstanding researcher who did an enormous amount over his career to improve the quality of medical research,” Andrew Carr, head of the Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences at Oxford, says in a memorial on the department’s website. “His simple message was, if you are going to do research on patients then do it well and report it honestly. This approach has improved standards of care all over the world.”

Altman studied statistics at the University of Bath and was a statistician at the Medical Research Council’s Clinical Research Centre for more than a decade, helping researchers develop ways to analyze their data. In 1986, he and collaborator Martin Bland published an incredibly popular technique to visually compare two ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies